TS
PFE icon

Triglav Skladi’s Pfizer PFE Stock Holding History

Triglav Skladi’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.02M Buy
333,000
+16,300
+5% +$426K 0.42% 46
2026
Q1 		$8.89M Sell
316,700
-99,092
-24% -$2.64M 0.62% 31
2025
Q4 		$10.4M Buy
415,792
+99,092
+31% +$2.5M 0.65% 35
2025
Q3 		$8.07M Hold
316,700
– – 0.53% 41
2025
Q2 		$7.68M Hold
316,700
– – 0.55% 36
2025
Q1 		$8.03M Hold
316,700
– – 0.67% 37
2024
Q4 		$8.4M Buy
+316,700
New +$8.59M 0.66% 35

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Triglav Skladi's PFE Position: Q2 2026 in Review

Triglav Skladi increased its Pfizer (PFE) stake by 5.1% in Q2 2026, buying an estimated $426K and bringing the position to 333,000 shares worth $8.02M. The position accounts for 0.42% of the portfolio, ranked #46.

Triglav Skladi first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $10.4M in Q4 2025. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Triglav Skladi held 333,000 shares of Pfizer worth $8.02M as of Q2 2026.
  • Triglav Skladi bought 16,300 Pfizer shares in Q2 2026, an estimated $426K.
  • Pfizer made up 0.42% of Triglav Skladi's portfolio in Q2 2026, its #46 holding.
  • Triglav Skladi first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Triglav Skladi's Pfizer position peaked at $10.4M in Q4 2025.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Triglav Skladi's 13F filing for Q2 2026, filed 11 Aug 2026.